Thalidomide-Induced Orofacial Neuropathy

被引:5
作者
Anyanwu, Cynthia O. [1 ,2 ]
Stewart, Campbell L. [2 ]
Werth, Victoria P. [1 ,2 ]
机构
[1] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
CUTANEOUS LUPUS-ERYTHEMATOSUS;
D O I
10.1097/RHU.0000000000000176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:399 / 400
页数:2
相关论文
共 9 条
[1]   Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients [J].
Bastuji-Garin, S ;
Ochonisky, S ;
Bouche, P ;
Gherardi, RK ;
Duguet, C ;
Djerradine, Z ;
Poli, F ;
Revuz, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) :1020-1026
[2]  
Callen JP, 2013, JAMA DERMATOL
[3]   Thalidomide-induced neuropathy [J].
Chaudhry, V ;
Cornblath, DR ;
Corse, A ;
Freimer, M ;
Simmons-O'Brien, E ;
Vogelsang, G .
NEUROLOGY, 2002, 59 (12) :1872-1875
[4]   Thalidomide-induced perioral neuropathy [J].
Elad, S ;
Galili, D ;
Garfunkel, AA ;
Or, R .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1997, 84 (04) :362-364
[5]   Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden [J].
Gronhagen, C. M. ;
Fored, C. M. ;
Linder, M. ;
Granath, F. ;
Nyberg, F. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (02) :296-305
[6]   Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma [J].
Johnson, David C. ;
Corthals, Sophie L. ;
Walker, Brian A. ;
Ross, Fiona M. ;
Gregory, Walter M. ;
Dickens, Nicholas J. ;
Lokhorst, Henk M. ;
Goldschmidt, Hartmut ;
Davies, Faith E. ;
Durie, Brian G. M. ;
Van Ness, Brian ;
Child, J. Anthony ;
Sonneveld, Pieter ;
Morgan, Gareth J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) :797-804
[7]   SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS ASSOCIATED WITH HYDROCHLOROTHIAZIDE THERAPY [J].
REED, BR ;
HUFF, JC ;
JONES, SK ;
ORTON, PW ;
LEE, LA ;
NORRIS, DA .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :49-51
[8]   SUB-ACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS - CUTANEOUS MARKER FOR A DISTINCT LUPUS-ERYTHEMATOSUS SUBSET [J].
SONTHEIMER, RD ;
THOMAS, JR ;
GILLIAM, JN .
ARCHIVES OF DERMATOLOGY, 1979, 115 (12) :1409-1415
[9]   Thalidomide: dermatological indications, mechanisms of action and side-effects [J].
Wu, JJ ;
Huang, DB ;
Pang, KR ;
Hsu, S ;
Tyring, SK .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (02) :254-273